Kidron Miriam — SEC insider filings
SEC reporting owner CIK 1409232. 19 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2021-02-08 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 100,000 shares, $201,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 100,000 shares @ $2.01 ($201,000) in ORAMED PHARMACEUTICALS INC., filed 2023-03-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer, Director | 18 | — | 1 leg · 100,000 sh · $201,000 | 32 |
| Lifeward Ltd. (LFWD) | Director | 1 | — | — | 1 |
Insider filings — Kidron Miriam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 357,000 · Grant/award (A): 242,000 | EDGAR |
| 2026-09-25 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 208,125 · Grant/award (A): 209,291 · Disposition to issuer (D): 104,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 69,999 (derivative) · Disposition to issuer (D): 47,000 (derivative) · +2 more | EDGAR |
| 2026-03-31 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Tax withholding (F): 435,084 @ $3.31 | EDGAR |
| 2026-03-27 | 4 | Lifeward Ltd. (LFWD) | Grant/award (A): 7,657 @ $0 | EDGAR |
| 2026-03-18 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 119,558 @ $0 | EDGAR |
| 2026-01-29 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Option exercise (M): 19,000 @ $0 · Option exercise (M): 19,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 86,166 @ $0 | EDGAR |
| 2026-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 121,331 @ $0 · Grant/award (A): 115,000 @ $0 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 74,000 @ $0 · Grant/award (A): 52,000 @ $0 · Grant/award (A): 66,667 @ $0 | EDGAR |
| 2025-01-06 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 207,000 | EDGAR |
| 2024-11-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 | EDGAR |
| 2024-01-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 295,500 | EDGAR |
| 2023-05-31 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 53,500 | EDGAR |
| 2023-04-20 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 213,000 | EDGAR |
| 2023-03-15 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale (S): 100,000 @ $2.01 | EDGAR |
| 2022-08-01 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 34,000 · Grant/award (A): 84,000 | EDGAR |
| 2022-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 42,000 · Grant/award (A): 72,000 (derivative) @ $0 | EDGAR |
| 2021-09-02 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 66,666 | EDGAR |
| 2021-02-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1409232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs